Pancreatic Cancer Research

ResearcherUniversity Health NetworkNo recent work listed

Laura Ann Dawson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9068-6872; OpenAlex author ID A5037659354. Sources: ClinicalTrials.gov.

Their work

Papers
8 (first author 1, last author 0)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: 1 trial · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper

Papers 8

  1. Inflammatory Cytokines and Radiotherapy in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/biomedicines10123215↗
  2. A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy. Co-author DOI 10.1016/j.clon.2021.03.007↗
  3. Magnetic Resonance Guided Radiation Therapy for Pancreatic Adenocarcinoma, Advantages, Challenges, Current Approaches, and Future Directions. Co-author DOI 10.3389/fonc.2021.628155↗
  4. Dose-Escalated Radiation Therapy for Pancreatic Cancer: A Simultaneous Integrated Boost Approach. Co-author DOI 10.1016/j.prro.2020.01.012↗
  5. Radiation Therapy for Pancreatic Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Co-author DOI 10.1016/j.prro.2019.06.016↗
  6. Induction gemcitabine plus concurrent gemcitabine and radiotherapy for locally advanced unresectable or resected pancreatic cancer. Co-author DOI 10.1016/j.clon.2014.01.003↗
  7. Quality of life in a prospective, multicenter phase 2 trial of neoadjuvant full-dose gemcitabine, oxaliplatin, and radiation in patients with resectable or bor… Co-author DOI 10.1016/j.ijrobp.2014.05.053↗
  8. A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.28117↗

Trials 1

  1. MR Guidance for Liver and Pancreas Principal investigator NCT03582189↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sylvia S. W. Ng · 1 shared paper, 2022 · strength 0.33
  2. William Adrian Hall · 3 shared papers, 2019–2021 · strength 0.29
  3. Joseph M. Herman · 4 shared papers, 2013–2020 · strength 0.25
  4. Bradley A. Erickson · 2 shared papers, 2020–2021 · strength 0.21
  5. Katharine L. Aitken · 2 shared papers, 2020–2021 · strength 0.21
  6. Sten D. Myrehaug · 2 shared papers, 2020–2021 · strength 0.21
  7. Eugene Jon Koay · 2 shared papers, 2020–2021 · strength 0.21
  8. Christopher H. Crane · 2 shared papers, 2020–2021 · strength 0.21
  9. Alice Chia-Chi Wei · 3 shared papers, 2013–2021 · strength 0.17
  10. James D. Brierley · 2 shared papers, 2014–2021 · strength 0.14
  11. Steve Gallinger · 2 shared papers, 2014–2021 · strength 0.14
  12. Cullen M. Taniguchi · 1 shared paper, 2020 · strength 0.11
  13. Michael Frederick Bassetti · 1 shared paper, 2021 · strength 0.10
  14. Michael David Chuong · 1 shared paper, 2021 · strength 0.10
  15. Lois A. Daamen · 1 shared paper, 2021 · strength 0.10
  16. Hanne D. Heerkens · 1 shared paper, 2021 · strength 0.10
  17. Gert J. Meijer · 1 shared paper, 2021 · strength 0.10
  18. E.S. Paulson · 1 shared paper, 2021 · strength 0.10
  19. Parag Jitendra Parikh · 1 shared paper, 2021 · strength 0.10
  20. Percy P. Lee · 1 shared paper, 2021 · strength 0.10
  21. Sangeetha N. Kalimuthu · 1 shared paper, 2021 · strength 0.10
  22. Ahmed M. Elamir · 1 shared paper, 2021 · strength 0.10
  23. Sean Patrick Cleary · 1 shared paper, 2021 · strength 0.10
  24. Ali Hosni · 1 shared paper, 2021 · strength 0.10
  25. Grainne Mary O'Kane · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.